It is a surprise there is still no announcement by ACR management re the excellent sales of Axiron as reported by Eli Lilly. If they ever wanted to help shareholders and diminish the effect of the constant shorting of ACR stock over the past month now is the time.
I couldn't imagine the previous MD Richard Treagus missing this opportunity, which reminds me have they filled this position yet? I for one want Richard back and quickly.
It is a surprise there is still no announcement by ACR...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.89M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3903 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable